logo.jpg.jpg
ViaDerma Completes First Shipment of 500,000 Units to Nigeria
September 10, 2024 08:00 ET | ViaDerma, Inc.
LOS ANGELES, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC: VDRM), a specialty pharmaceutical company known for developing innovative transdermal drug delivery systems, is pleased to...
logo.jpg.jpg
ViaDerma Announces Shipment of 500,000 Units of its Flagship Product to Nigeria
August 13, 2024 08:00 ET | ViaDerma, Inc.
LOS ANGELES, Aug. 13, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC: VDRM), a leader in innovative wound care solutions, is excited to announce that a shipment of 500,000 units of its flagship...
logo.jpg.jpg
ViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key Hires
August 01, 2024 08:00 ET | ViaDerma, Inc.
ViaDerma announces strategic new agreements to move forward its global expansion.
logo.jpg.jpg
ViaDerma Provides Highlights of Quarterly Financial Report
June 06, 2024 08:00 ET | ViaDerma, Inc.
ViaDerma provides an update on their most recent quarterly financial report
logo.jpg.jpg
ViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & More 
July 06, 2023 08:00 ET | ViaDerma, Inc.
LOS ANGELES, July 06, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is very pleased to announce several exciting business updates for current and prospective shareholders, partners, and...
logo.jpg.jpg
ViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product
March 16, 2023 08:00 ET | ViaDerma, Inc.
LOS ANGELES, March 16, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce that the company has recently submitted their application for their planned minoxidil hair...
logo.jpg.jpg
ViaDerma Engages Intent Sciences to Power Up Digital Marketing & Brand Development
January 12, 2023 08:00 ET | ViaDerma, Inc.
LOS ANGELES, Jan. 12, 2023 (GLOBE NEWSWIRE) --  ViaDerma, Inc., (OTC Pink: VDRM) is pleased to announce that they have engaged the growth marketing services of INTENT SCIENCES who will help grow the...
logo.jpg.jpg
ViaDerma's 2021 Annual Report Shows Strong Revenue Growth Over the Previous Year
March 31, 2022 05:00 ET | ViaDerma, Inc.
LOS ANGELES, March 31, 2022 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) announces the release of its 2021 Annual Report on the OTC Markets. The Company ended the year with...
logo.jpg.jpg
ViaDerma, Inc. Files Amended Financial Statements
August 24, 2021 10:23 ET | ViaDerma, Inc.
LOS ANGELES, Aug. 24, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) published a Quarterly Report for the three months ended March 31, 2021, on the OTC Markets website...
logo.jpg.jpg
ViaDerma, Inc. Announces Expansion of its Current Licensing Agreement and Provides Additional Company Updates
June 02, 2021 05:00 ET | ViaDerma, Inc.
LOS ANGELES, June 02, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to announce they have expanded their current licensing agreement with a home health wound care...